Simultaneous determination of testosterone metabolites in liver microsomes using column-switching semi-microcolumn high-performance liquid chromatography.
A sensitive and selective column-switching semi-microcolumn high-performance liquid chromatographic (HPLC) method has been developed for the simultaneous determination of testosterone and eight of its metabolites (6alpha-, 6beta-, 16alpha-, 16beta-, 7alpha-, 2alpha-, and 2beta-hydroxytestosterone, and androstenedione) in liver microsomes. After incubation for 10 min, testosterone and its metabolites were extracted from the microsomes with ethyl acetate, and the extract was evaporated to dryness. The residue was dissolved in the mobile phase and loaded onto the HPLC system. The analytes were first concentrated in a precolumn and subsequently transferred to the analytical column, where they were separated using linear gradient elution. A UV detector set at 254 nm was used to detect the analytes. This newly developed method clearly separated TES and the metabolites with high resolution and was found to be reproducible with intra- and interday variability of <10.7%. This method has been subsequently used to determine the testosterone hydroxylation activities catalyzed by 15 different recombinant CYP isozymes. The results confirmed the formation of stereoselectively hydroxylated metabolites by each CYP isozyme.
Tachibana
S
S
Drug Metabolism and Physicochemical Property Research Laboratory, Daiichi Pharmaceutical Company Ltd., 1-16-13 Kitakasai, Edogawa-ku, Tokyo 134-8630, Japan. tachiroq@daiichipharm.co.jp
Tanaka
M
M
D000818:Animals; D002851:Chromatography, High Pressure Liquid / Q000295:instrumentation / Q000379:methods*; D006801:Humans; D006900:Hydroxylation; D006915:Hydroxytestosterones / Q000378:metabolism; D008862:Microsomes, Liver / Q000737:chemistry / Q000201:enzymology / Q000378:metabolism*; D051381:Rats; D015203:Reproducibility of Results; D013739:Testosterone / Q000032:analysis / Q000378:metabolism*
D006915:Hydroxytestosterones; D013739:Testosterone; C025591:6 beta-hydroxytestosterone